PU.1 silencing leads to terminal differentiation of erythroleukemia cells

被引:10
作者
Atar, O [1 ]
Levi, BZ [1 ]
机构
[1] Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel
关键词
PU.1; friend erythroleukemia; siRNA; MEL cells;
D O I
10.1016/j.bbrc.2005.02.109
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor PU.1 plays a central role in development and differentiation of hematopoietic cells. Evidence from PU.1 knockout mice indicates a pivotal role for PU.1 in myeloid lineage and B-lymphocyte development. In addition, PU.1 is a key player in the development of Friend erythroleukemia disease, which is characterized by proliferation and differentiation arrest of proerythrocytes. To study the role of PU.1 in erythroleukemia, we have used murine erythroleukemia cells, isolated from Friend virus-infected mice. Expression of PU.1 small interfering RNA in these cells led to significant inhibition of PU.1 levels. This was accompanied by inhibition of proliferation and restoration in the ability of the proerythroblastic cells to produce hemoglobin, i.e., reversion of the leukemic phenotype. The data suggest that overexpression of PU.1 gene is the immediate cause for maintaining the leukemic phenotype of the disease by retaining the self-renewal capacity of transformed erythroblastic cells and by blocking the terminal differentiation program towards erythrocytes. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1288 / 1292
页数:5
相关论文
共 16 条
[1]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[2]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[3]   Transcriptional regulation of erythropoiesis: an affair involving multiple partners [J].
Cantor, AB ;
Orkin, SH .
ONCOGENE, 2002, 21 (21) :3368-3376
[4]   The importance of PU.1 concentration in hematopoietic lineage commitment and maturation [J].
Dahl, R ;
Simon, MC .
BLOOD CELLS MOLECULES AND DISEASES, 2003, 31 (02) :229-233
[5]  
DELGADO MD, 1994, ONCOGENE, V9, P1723
[6]   PIP, A NOVEL IRF FAMILY MEMBER, IS A LYMPHOID-SPECIFIC, PU.1-DEPENDENT TRANSCRIPTIONAL ACTIVATOR [J].
EISENBEIS, CF ;
SINGH, H ;
STORB, U .
GENES & DEVELOPMENT, 1995, 9 (11) :1377-1387
[7]   Reprogramming erythroleuekmia cells to terminal differentiation and terminal cell division [J].
Matushansky, I ;
Radparvar, F ;
Rekhtman, N ;
Skoultchi, A .
FRONTIERS IN BIOSCIENCE, 2000, 5 :D488-D492
[8]   IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: Characterization of a new subtype of IFN-stimulated response element [J].
Meraro, D ;
Gleit-Kielmanowicz, M ;
Hauser, H ;
Levi, BZ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (12) :6224-6231
[9]  
Meraro D, 1999, J IMMUNOL, V163, P6468
[10]   Friend erythroleukemia revisited [J].
Ney, PA ;
D'Andrea, AD .
BLOOD, 2000, 96 (12) :3675-3680